hiPSCs therapy(Eyestem Research)

N/A

Report date: 2024/05/07 20:00:09

Base Information

Drug NamehiPSCs therapy(Eyestem Research)

Drug Alias Namehuman induced Pluripotent Stem Cells therapy(Eyestem Research)hiPSCs (human induced Pluripotent Stem Cells) derived Retinal Pigment Epithelial Cells therapy(Eyestem Research)Eyecyte-RPE™

ClassificationCell and gene therapy > Cell therapy > Source of cells > iPSC-derivedCell and gene therapy > Cell therapy > Somatic cell > Retinal pigment epithelial cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsGeographic AtrophyMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndia

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesEyestem Research Pvt Ltd

China Registration ClassN/A

Develop Information

Active CompaniesEyestem Research Pvt Ltd

Inactive CompaniesN/A

Active IndicationsGeographic AtrophyMacular Degeneration

Inactive IndicationsN/A

Other Information

ATC CodeN/A